Label-free Array Systems Market Trends

Label-free Array Systems Market Trends

The rising cases of chronic and infectious diseases is a significant driver for market. With increasing incidences of chronic and infectious diseases, there is a heightened demand for advanced diagnostic tools that can provide rapid, accurate, and real-time detection of biomarkers associated with these diseases.
 

• According to the World Health Organization (WHO), in 2024, over 35 million new cancer cases are predicted in 2050, a 77% increase from the 20 million cases in 2022.
   
• Similarly, as per the same report, about 422 million people worldwide have diabetes, the majority living in low-and middle-income countries, and 1.5 million deaths are directly attributed to diabetes each year. Both the number of cases and the prevalence of diabetes have been steadily increasing over the past few decades.
   
• The surge in chronic and infectious diseases necessitates the development of new therapeutics. Label-free array systems are essential in the drug discovery process, as they enable detailed analysis of biomolecular interactions, helping researchers identify and develop effective drugs more efficiently.
   
• Chronic diseases such as cancer, diabetes, and cardiovascular diseases, often require personalized treatment approaches. Label-free array systems facilitate the study of individual patient samples to identify specific biomarkers and tailor treatments, thereby increasing the growth of the market.